Overview

Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment

Status:
Unknown status

Trial end date:
2017-09-01

Target enrollment:

Participant gender:

Summary

Helicobacter pylori (H. pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H. pylori eradication is an effective approach to reduce the incidence of those pathologies.

Phase:

Phase 4

Details

Lead Sponsor:

Shandong University

Collaborators:

Binzhou People's Hospital
General Hospital of Jinan Military Region
Liaocheng People's Hospital
Shandong Provincial Hospital

Treatments:

Amoxicillin
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Bismuth
Clarithromycin
Furazolidone
Levofloxacin
Metronidazole
Ofloxacin
Proton Pump Inhibitors
Tetracycline
Tinidazole